| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K24690302 |
| PharmacoGx | BRD-K24690302 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RSL1D1 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | BRI3BP | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | CREBRF | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | MTMR1 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | FAM19A5 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.03 |
| mRNA | TMEM230 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | ZKSCAN2 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | ZYG11A | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | VEGFC | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | NFKBIE | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
